Cargando…
Biased Agonism of Three Different Cannabinoid Receptor Agonists in Mouse Brain Cortex
Cannabinoid receptors are able to couple to different families of G proteins when activated by an agonist drug. It has been suggested that different intracellular responses may be activated depending on the ligand. The goal of the present study was to characterize the pattern of G protein subunit st...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5095132/ https://www.ncbi.nlm.nih.gov/pubmed/27867358 http://dx.doi.org/10.3389/fphar.2016.00415 |
Sumario: | Cannabinoid receptors are able to couple to different families of G proteins when activated by an agonist drug. It has been suggested that different intracellular responses may be activated depending on the ligand. The goal of the present study was to characterize the pattern of G protein subunit stimulation triggered by three different cannabinoid ligands, Δ(9)-THC, WIN55212-2, and ACEA in mouse brain cortex. Stimulation of the [(35)S]GTPγS binding coupled to specific immunoprecipitation with antibodies against different subtypes of G proteins (Gα(i1), Gα(i2), Gα(i3), Gα(o), Gα(z), Gα(s), Gα(q/11), and Gα(12/13)), in the presence of Δ(9)-THC, WIN55212-2 and ACEA (submaximal concentration 10 μM) was determined by scintillation proximity assay (SPA) technique in mouse cortex of wild type, CB(1) knock-out, CB(2) knock-out and CB(1)/CB(2) double knock-out mice. Results show that, in mouse brain cortex, cannabinoid agonists are able to significantly stimulate not only the classical inhibitory Gα(i/o) subunits but also other G subunits like Gα(z), Gα(q/11), and Gα(12/13). Moreover, the specific pattern of G protein subunit activation is different depending on the ligand. In conclusion, our results demonstrate that, in mice brain native tissue, different exogenous cannabinoid ligands are able to selectively activate different inhibitory and non-inhibitory Gα protein subtypes, through the activation of CB(1) and/or CB(2) receptors. Results of the present study may help to understand the specific molecular pathways involved in the pharmacological effects of cannabinoid-derived drugs. |
---|